nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals
|
Castanheira, Mariana |
|
|
58 |
5 |
p. |
artikel |
2 |
Amikacin in combination with zinc pyrithione prevents growth of a multidrug-resistant carbapenem-resistant Klebsiella pneumoniae isolate
|
Magallon, Jesus |
|
|
58 |
5 |
p. |
artikel |
3 |
A new mutation in mgrb mediating polymyxin resistance in Klebsiella variicola
|
Lenzi, Michael H |
|
|
58 |
5 |
p. |
artikel |
4 |
Antimicrobial effect of auranofin against Acanthamoeba spp.
|
Loufouma Mbouaka, Alvie |
|
|
58 |
5 |
p. |
artikel |
5 |
Antimicrobial Susceptibility among Gram-Negative Isolates in Pediatric Patients in Europe from 2013–2018 Compared to 2004–2012: Results from the ATLAS Surveillance Study
|
Seifert, Harald |
|
|
58 |
5 |
p. |
artikel |
6 |
Cefazolin versus cloxacillin as definitive antibiotic therapy for methicillin-susceptible Staphylococcus aureus spinal epidural abscess: a retrospective cohort study
|
Bai, Anthony D. |
|
|
58 |
5 |
p. |
artikel |
7 |
Corrigendum to “Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli” [International Journal of Antimicrobial Agents, Volume 56, Issue 6, December 2020, 106183]
|
McKernan, Patrick |
|
|
58 |
5 |
p. |
artikel |
8 |
Distribution of mcr genes among carbapenem-resistant Enterobacterales clinical isolates: high prevalence of mcr-positive Enterobacter cloacae complex in Seoul, Republic of Korea
|
Kim, Jin Seok |
|
|
58 |
5 |
p. |
artikel |
9 |
Extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in humans and from food-producing animals in Italy: a ‘One Health’ study
|
Giufrè, Maria |
|
|
58 |
5 |
p. |
artikel |
10 |
HISTORY OF THE INTERNATIONAL SOCIETY OF ANTIMICROBIAL CHEMOTHERAPY (ISAC)
|
|
|
|
58 |
5 |
p. |
artikel |
11 |
Hydroxychloroquine plus azithromycin early treatment of mild COVID-19 in an outpatient setting: a randomized, double-blinded, placebo-controlled clinical trial evaluating viral clearance
|
Rodrigues, Cristhieni |
|
|
58 |
5 |
p. |
artikel |
12 |
In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates
|
Meletiadis, Joseph |
|
|
58 |
5 |
p. |
artikel |
13 |
Longitudinal Genomic Characterization of Carbapenemase-producing Enterobacteriaceae (CPE) Reveals Changing Pattern of CPE Isolated in Hong Kong Hospitals
|
Zhu, Chendi |
|
|
58 |
5 |
p. |
artikel |
14 |
Pharmacokinetics of fluconazole and ganciclovir as combination antimicrobial chemotherapy on ECMO: a case report
|
Dhanani, Jayesh A. |
|
|
58 |
5 |
p. |
artikel |
15 |
Polymyxin resistance in Enterobacterales: overview and epidemiology in the Americas
|
Rodríguez-Santiago, J. |
|
|
58 |
5 |
p. |
artikel |
16 |
The cathelicidin-derived close-to-nature peptide D-11 sensitises Klebsiella pneumoniae to a range of antibiotics in vitro, ex vivo and in vivo
|
Cebrián, Rubén |
|
|
58 |
5 |
p. |
artikel |
17 |
Title Page & Editorial Board
|
|
|
|
58 |
5 |
p. |
artikel |
18 |
Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept
|
Cojutti, Pier Giorgio |
|
|
58 |
5 |
p. |
artikel |
19 |
Vertebral osteomyelitis caused by vancomycin-resistant Enterococcus spp.: a case series
|
Russo, Alessandro |
|
|
58 |
5 |
p. |
artikel |